Fasedienol Market Size and Forecast As an investigational drug, Fasedienol (PH-94B) currently does not hold a market size, but its potential is tied to the vast and growing anxiety disorders market, particularly…
Category: Pharmaceutical
GLP-1 for IBD Market: Size, Forecast, Drivers, and Key Trends
GLP-1 for IBD Market Size and Forecast The market for GLP-1 receptor agonists (GLP-1 RAs) specifically targeting Inflammatory Bowel Disease (IBD) is currently nascent but holds significant future potential. While GLP-1 RAs…
BRAF MEK Combo Generics Market: Size, Forecast, Drivers, and Key Trends
BRAF MEK Combo Generics Market Size and Forecast The BRAF MEK combination generics market is anticipated to emerge as branded combination therapies, such as Tafinlar and Mekinist, face patent expiration in the…
Schiz Cobitolimod Market: Size, Forecast, Drivers, and Key Trends
Cobitolimod Market Size and Forecast Cobitolimod, an investigational drug for moderate-to-severe ulcerative colitis (UC), targets the substantial unmet need in patients who fail conventional treatments. As a Toll-like receptor 9 (TLR9) agonist,…
CCK for Pancreas Market: Size, Forecast, Drivers, and Key Trends
Cholecystokinin (CCK) for Pancreas Diagnostic Aid Market Size and Forecast The market for Cholecystokinin (CCK) related to pancreatic diagnostics is specialized, primarily involving its use as an injectable agent to stimulate pancreatic…
MSI Tebotelimab Market: Size, Forecast, Drivers, and Key Trends
MSI-H/dMMR Market Size and Forecast (Relevant to Tebotelimab’s Target) The market for treatments targeting MSI-H/dMMR (Microsatellite Instability-High/deficient Mismatch Repair) cancers is substantial and rapidly expanding. This segment was valued at approximately USD…
OCD Tranylcypromine Market: Size, Forecast, Drivers, and Key Trends
Tranylcypromine for OCD: Market Size and Forecast The market specifically for Tranylcypromine in treating Obsessive-Compulsive Disorder (OCD) is considered a niche segment within the broader OCD drug landscape. While Serotonergic Reuptake Inhibitors…
Regorafenib for Liver Market: Size, Forecast, Drivers, and Key Trends
Regorafenib for Liver Market Size and Forecast Regorafenib (Stivarga) holds a significant position as a second-line treatment option for patients with hepatocellular carcinoma (HCC), or liver cancer, who have previously been treated…
NTRK Alt Market: Size, Forecast, Drivers, and Key Trends
NTRK Alt Market Size and Forecast The NTRK fusion-positive advanced solid tumor market is a highly specialized segment within oncology, defined by actionable genomic alterations. Market growth is driven by the efficacy…
PTSD Ganaxolone Market: Size, Forecast, Drivers, and Key Trends
PTSD Ganaxolone Market Size and Forecast The Post-Traumatic Stress Disorder (PTSD) treatment market is substantial, valued at around USD 2.28-2.37 billion in 2024/2025, with projections indicating growth up to USD 3.42 billion…